Overview

Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia

Status:
Recruiting
Trial end date:
2022-06-08
Target enrollment:
Participant gender:
Summary
Study to compare the effects of the investigational new drug (PF-06946860) and a placebo on appetite and to find out how participants with advanced cancer and anorexia feel after receiving repeated subcutaneous (SC-injected under the skin) doses.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer